Glossopharyngeal Nerve Block on Post Tonsillectomy Pain Among Egyptian Children

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05109416

Enrollment

210

Registered

2021-11-05

Start date

2021-10-17

Completion date

2022-03-22

Last updated

2022-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Tonsillectomy Pain

Keywords

Glossopharyngeal nerve block

Brief summary

Tonsillectomy is one of most common performed surgical procedure in children . tonsillectomy or adenotonsillectomy have high incidence of Post operative pain , it is very important and significant problem because it can lead to decrease oral intake and dehydration

Detailed description

Tonsillectomy is one of the most common performed surgical procedure in children. Tonsillectomy or adenotonsillectomy have high incidence of Post operative pain incidence . There is still debate about the optimal analgesia for this common procedure , different methods have been described including intraoperative anesthetic pain regimens , adjustment of surgical technique , intraoperative local anesthetic injection and use of pharmacotherapy post operative . The main goal of the preventive analgesia is the pain releif with minimum side effect . The objective of this study is to investigate and compare the effect of Glossopharyngeal nerve block for relief of pain on children following adenotonsillectomy . This is prospective , double blinded , randomized study

Interventions

DRUGBupivacaine Hydrochloride 0.5% Injection Solution

Local anesthetic

DRUGSaline 0.9%

Isotonic crystaloid

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

7 Years to 15 Years

Healthy volunteers

Inclusion criteria

* average weight is 10\_50 kg * patient is generally stable * indication of tonsillectomy is recurrent tonsillitis * Ability to self report pain

Exclusion criteria

* Hypersensitivity to bupivacaine * Obstructive sleep apnea syndrome * Pulmonary or cardic diseases

Design outcomes

Primary

Measure	Time frame	Description
The first call for analgesia	In 24 hours	Pain assessment using VAS scale

Secondary

Measure	Time frame	Description
The analgesic consumption	In 24 hours	The total analgesic consumption for pain rest and swallowing

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026